William Schaffner
Impact in
- Infectious Diseases top 0.1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Antimicrobial Resistance in Staphylococcus
- Microbiology top 0.05%
- Bacterial Infections and Vaccines
Papers in
- Epidemiology 229
- Pneumonia and Respiratory Infections 89
- Influenza Virus Research Studies 87
- Respiratory viral infections research 20
-
- Infection Control in Healthcare 47
- Antimicrobial Resistance in Staphylococcus 39
- COVID-19 Clinical Research Studies 23
- Co-authors
- Allen S. Craig (50 shared papers)M. GINNIE FARLEY (77 shared papers)Lee H. Harrison (97 shared papers)Ann R Thomas (77 shared papers)Marie R. Griffin (30 shared papers)Arthur Lawrence Reingold (57 shared papers)Ruth Lynfield (86 shared papers)Cynthia G. Whitney (22 shared papers)
- Journals
- Clinical Infectious Diseases (73 papers)The Journal of Infectious Diseases (37 papers)Open Forum Infectious Diseases (37 papers)MMWR Morbidity and Mortality Weekly Report (34 papers)New England Journal of Medicine (23 papers)
- Partner nations
- United StatesKenyaUganda
In The Last Decade
William Schaffner
558 papers receiving 30.4k citations
William Schaffner's Hit Papers
Peers
Comparison fields: 5 of 194
- Infectious Diseases 7k
- Microbiology 2.3k
- Epidemiology 11.1k
- Applied Microbiology and Biotechnology 763
- Health 1.9k
Countries citing papers authored by William Schaffner
This map shows the geographic impact of William Schaffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Schaffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Schaffner more than expected).
Fields of papers citing papers by William Schaffner
This network shows the impact of papers produced by William Schaffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Schaffner. The network helps show where William Schaffner may publish in the future.
Co-authors
The 25 scholars most cited alongside William Schaffner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 578 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 Hit paper breakdown → | 2020 | 1859 |
| 2 | Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine Hit paper breakdown → | 2009 | 1127 |
| 3 | Psychotropic Drug Use and the Risk of Hip Fracture Hit paper breakdown → | 1987 | 850 |
| 4 | Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae Hit paper breakdown → | 2006 | 740 |
| 5 | Bacterial Meningitis in the United States, 1998–2007 Hit paper breakdown → | 2011 | 735 |
| 6 | Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004 Hit paper breakdown → | 2007 | 641 |
| 7 | Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance Hit paper breakdown → | 2015 | 622 |
| 8 | Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study Hit paper breakdown → | 2006 | 530 |
| 9 | 2020 | 492 | |
| 10 | 2008 | 429 | |
| 11 | 2020 | 413 | |
| 12 | 2009 | 408 | |
| 13 | 2006 | 389 | |
| 14 | Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990–2007 Hit paper breakdown → | 2009 | 375 |
| 15 | Nonsteroidal Anti-Inflammatory Drug Use and Death from Peptic Ulcer in Elderly Persons Hit paper breakdown → | 1988 | 359 |
| 16 | 1980 | 337 | |
| 17 | 2009 | 323 | |
| 18 | 2005 | 321 | |
| 19 | 2009 | 320 | |
| 20 | Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015 Hit paper breakdown → | 2019 | 294 |
About William Schaffner
William Schaffner is a scholar working on Epidemiology, Infectious Diseases, Microbiology, Health and Public Health, Environmental and Occupational Health, having authored 578 papers that have together received 33.5k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (89 papers), Influenza Virus Research Studies (87 papers), Infection Control in Healthcare (47 papers), Vaccine Coverage and Hesitancy (42 papers), Antimicrobial Resistance in Staphylococcus (39 papers), Bacterial Infections and Vaccines (35 papers), COVID-19 Clinical Research Studies (23 papers) and Respiratory viral infections research (20 papers). The work is most often cited by research in Infectious Diseases (7k citations), Microbiology (2.3k citations), Epidemiology (11.1k citations), Applied Microbiology and Biotechnology (763 citations) and Health (1.9k citations). William Schaffner has collaborated with scholars based in United States, Kenya and Uganda. Frequent co-authors include Allen S. Craig, M. GINNIE FARLEY, Lee H. Harrison, Ann R Thomas, Marie R. Griffin, Arthur Lawrence Reingold, Ruth Lynfield, Cynthia G. Whitney, Wayne A. Ray and Nancy M. Bennett. Their work appears in journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases, Open Forum Infectious Diseases, MMWR Morbidity and Mortality Weekly Report and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.